Overall rank by patents
#26,034
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 17 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS).
The verdict
Checkerspot holds 10 US patents across 17 technology areas, rank #26,034 of 50,000 tracked assignees.
Checkerspot, Inc. has been granted 10 US utility patents between 2021 and 2025, placing Checkerspot, Inc. at rank #26,034 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 29.8 claims per patent with primary concentration in C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS). As a US Corporation, Checkerspot, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Checkerspot sits between Chagrinovations, Llc (10 patents, rank #26,030) and Chronix Biomedical (10 patents, rank #26,038) - the closest US assignees by grant volume. The composite Innovation Score of 57.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Checkerspot, Inc.'s 29.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Checkerspot, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Chagrinovations, LLC
10 patents
Changzhou T&D International Trading Co., Ltd.
10 patents
Changzhou Tronly New Electronics Materials Co., Ltd.
10 patents
Chattem, Inc.
10 patents
Chiasma, Inc.
10 patents
China ENFI Engineering Corporation
10 patents
ChroniSense Medical Ltd.
10 patents
Chronix Biomedical
10 patents
Checkerspot, Inc.
10 patents
What this shows Checkerspot holds 10 patents at rank #26,034, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Checkerspot's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
58 Top 5% higher than 95% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 2 | 20.0% |
| 2023 | 3 | 30.0% |
| 2024 | 4 | 40.0% |
| 2025 | 1 | 10.0% |
Top 15 of 17 technology areas
Overall rank by patents
#26,034
Across all tracked assignees
57.9 out of 100
How to use this portfolio
Checkerspot's 10 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.